PDCD1 and neoplasm: The stable tumor burden is markedly decreased after administration of the anti-PD-1 antibody to the co-culture system of exhausted mesothelin-CAR-T cells and pleural mesothelioma cells115, thus showing that immune inhibitor blockade therapies delay exhaustion of CAR-T cells.